The emergence of pure chemical protein synthesis as a commercially viable method of drug design and production will create serious problems in the patent system. You have full access to this article ...
EL CAJON, Calif.--(BUSINESS WIRE)-- PURE Bioscience, Inc. (PURE) (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver ...
Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www ...
Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback